首頁 > 市場調查報告書 > 製藥

生物標記循環系統

市場調查報告書

商品編碼

1508758

心臟生物標記市場：按產品類型、按應用、按測試地點、按地區

Cardiac Biomarkers Market, By Product Type, By Application, By Location of Testing, By Geography

出版日期: 2024年06月12日 | 出版商:

Coherent Market Insights | 英文 186 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球心臟生物標記市場預計到2024年將達到151億美元，預計2031年將達到363億美元，2024年至2031年的複合年成長率為13.3%。

圖 1. 2024 年心臟生物標記市場佔有率(%)（按地區）

心臟生物標記是指心肌受損或受壓時血液中存在的蛋白質。幫助檢測和監測各種心臟病。由於心血管疾病盛行率不斷上升以及世界上更容易心臟病的老年人數量不斷增加，心臟生物標記市場在過去幾年中出現了顯著成長。此外，技術進步正在導致高度敏感的生物標記的開發，從而能夠早期檢測心臟疾病。

市場動態：

全球心臟生物標記市場是由不斷成長的老年人口、日益增加的心血管疾病經濟負擔、擴大採用就地檢驗以及不斷增加的研究和開發所推動的。然而，圍繞新心臟生物標記核准的監管問題、缺乏認知以及不願採用新技術給市場參與企業帶來了挑戰。由於醫療保健支出增加、糖尿病和文明病負擔增加以及本土參與企業的出現，新興經濟體被視為提供市場開拓機會。主要參與企業專注於開發新型生物標記組合和可攜式測試設備，以改善患者監測和管理。

本研究的主要特點

該報告對全球心臟生物標記市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它揭示了各個細分市場的潛在收益成長機會，並說明了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
它包括基於公司亮點、產品系列、主要亮點、績效和策略等參數的全球心臟生物標記市場中主要企業的概況。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球心臟生物標記市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進入者和財務分析師。
透過用於全球心臟生物標記市場分析的各種策略矩陣，將促進相關人員的決策。

公司簡介
- Abbott Laboratories
- Life Diagnostics
- Roche Diagnostics
- Siemens Healthineers
- Danaher Corporation
- Becton, Dickinson and Company（BD）
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- bioMerieux SA
- Randox Laboratories Ltd.
- Ortho Clinical Diagnostics
- Myriad RBM
- DiaDexus Inc.
- Response Biomedical Corp.
- BG Medicine, Inc.
- Boston Scientific Corporation
- Cardiovascular Systems, Inc.
- Quidel Corporation

第10章分析師建議

升起和降落
綜合機會圖

第11章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI4576

The global cardiac biomarkers market is estimated to be valued at USD 15.10 Bn in 2024 and is expected to reach USD 36.30 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13.3% from 2024 to 2031.

Figure 1. Cardiac Biomarkers Market Share (%), By Region, 2024

Cardiac biomarkers refer to proteins that are present in blood when the heart muscle is damaged or stressed. They help detect and monitor various heart conditions. The cardiac biomarkers market has been witnessing significant growth over the past few years driven by the rising incidence of cardiovascular diseases and growing elderly population worldwide who are more prone to cardiac issues. Furthermore, ongoing technological advancements are allowing for the development of more sensitive biomarkers that can enable the earlier detection of cardiac conditions.

Market Dynamics:

The global cardiac biomarkers market is driven by the increasing geriatric population, rising economic burden of cardiovascular diseases, growing adoption of point-of-care testing, and ongoing research & development. However, regulatory issues regarding the approval of new cardiac biomarkers, lack of awareness, and reluctant acceptance of new technologies pose challenges to market players. The market sees opportunities in developing economies due to increasing healthcare spending, growing diabetes and lifestyle disease burden, and emergence of local players. Key players are focusing on developing novel biomarker panels and portable testing devices for improved patient monitoring and management.

Key Features of the Study:

This report provides an in-depth analysis of the global cardiac biomarkers market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global cardiac biomarkers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, bioMerieux, and Becton, Dickinson and Company.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global cardiac biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac biomarkers market.

Detailed Segmentation-

By Product Type:
- Myocardial Muscle Creatine Kinase (CK MB)
- Myoglobin
- Troponins (T and I)
- Brain Natriuretic Peptide (BNPs) or NT-proBNP
- Ischemia-modified Albumin (IMA)
- Others
By Application:
- Myocardial Infarction 35.5
- Congestive Heart Failure,
- Acute Coronary Syndrome,
- Atherosclerosis,
- Others
- Myocardial Infarction 35.5
- Congestive Heart Failure,
By Location of Testing:
- Laboratory Testing 70.1 %
- Point of Care Testing
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Abbott Laboratories
- Life Diagnostics
- Roche Diagnostics
- Siemens Healthineers
- Danaher Corporation
- Becton, Dickinson and Company (BD)
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- bioMerieux SA
- Randox Laboratories Ltd.
- Ortho Clinical Diagnostics
- Myriad RBM
- DiaDexus Inc.
- Response Biomedical Corp.
- BG Medicine, Inc.
- Boston Scientific Corporation
- Cardiovascular Systems, Inc.
- Quidel Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Location of Testing
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Cardiac Biomarkers Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Cardiac Biomarkers Market, By Product Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Myocardial Muscle Creatine Kinase (CK MB)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Myoglobin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn) Myoglobin
Troponins (T and I)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Brain Natriuretic Peptide (BNPs) or NT-proBNP
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Ischemia-modified Albumin (IMA)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Cardiac Biomarkers Market, By Application, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Myocardial Infarction
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Congestive Heart Failure
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Acute Coronary Syndrome
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Atherosclerosis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Cardiac Biomarkers Market, By Location of Testing, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Laboratory Testing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Point of Care Testing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Cardiac Biomarkers Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Abbott Laboratories
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Life Diagnostics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Roche Diagnostics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Siemens Healthineers
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Danaher Corporation
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Becton, Dickinson and Company (BD)
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- bioMerieux SA
- Randox Laboratories Ltd.
- Ortho Clinical Diagnostics
- Myriad RBM
- DiaDexus Inc.
- Response Biomedical Corp.
- BG Medicine, Inc.
- Boston Scientific Corporation
- Cardiovascular Systems, Inc.
- Quidel Corporation